Daptomycin: A Viewpoint by Richard Quintiliani

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.4, 2004-01, pp. : 457-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Moxifloxacin: A Viewpoint by Richard Wise

By Wise R.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 374-374

Adis International

Access to resources Recommend Favorite

Duloxetine: A Viewpoint by Richard J. Millard

By Richard J. Millard

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2574-2575

Adis International

Access to resources Recommend Favorite

Bicalutamide: A Viewpoint by Richard K. Lo

By Lo R.K.

Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. : 2482-2483

Adis International

Access to resources Recommend Favorite

Daptomycin

By Fenton C. Keating G.M. Curran M.P.

Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. : 445-455

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules: A Viewpoint by Richard H. Weisler

By Weisler Richard H.

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 717-718

Adis International

Access to resources Recommend Favorite